This inventor holds 1 USPTO granted patent. Top assignees: Università Degli Studi Di Camerino, Universitá Degli Studi Di Padova. Active years: 2015.
Company Filing History:
1 out of 4 
1 out of 43 
Years Active: 2015
Title: The Innovative Contributions of Carlo Santini
Introduction
Carlo Santini is a notable inventor based in Camerino, Italy. He has made significant contributions to the field of oncology through his innovative research and patents. His work focuses on developing compounds that can effectively treat a variety of human solid tumors.
Latest Patents
Carlo Santini holds a patent for the compound [CU(thp)4]n[X]-n, which is designed for the treatment of a broad range of human solid tumors, including refractory tumors. This patent involves Cu(I) complexes of the type [Cu(thp)4][X], where thp refers to tris(hydroxymethyl)phosphine, and X is a counteranion. The invention is aimed at providing antineoplastic agents against solid tumors in humans.
Career Highlights
Throughout his career, Carlo Santini has worked with prestigious institutions such as the University of Padua and the University of Camerino. His research has been pivotal in advancing the understanding and treatment of solid tumors, showcasing his dedication to improving human health.
Collaborations
Carlo has collaborated with esteemed colleagues, including Cristina Marzano and Marina Porchia. These partnerships have further enriched his research and contributed to the development of innovative therapeutic solutions.
Conclusion
Carlo Santini's work exemplifies the impact of innovative research in the medical field. His contributions, particularly in the area of cancer treatment, highlight the importance of continued exploration and development of new therapeutic agents.